← All BC ADM Flashcard Decks

Safety & Risk Management Flashcards

7 cards from real BC ADM practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 7 Safety & Risk Management flashcards as text
  1. A patient with type 1 diabetes reports frequent hypoglycemia unawareness. Which strategy is MOST appropriate to restore hypoglycemia awareness?

    Answer: Increase the target HbA1c to allow higher glucose levels for several weeks

    Hypoglycemia unawareness can be reversed by short-term avoidance of hypoglycemia, which resets the glycemic threshold for counter-regulatory responses.

  2. Which of the following is the MOST significant risk factor for severe hypoglycemia in patients with long-standing type 1 diabetes?

    Answer: Impaired awareness of hypoglycemia (IAH)

    Impaired awareness of hypoglycemia substantially increases the risk of severe hypoglycemia because patients cannot recognize and treat early warning signs.

  3. A patient on insulin therapy is scheduled for a colonoscopy requiring bowel prep. What is the BEST recommendation for insulin management during the prep day?

    Answer: Reduce basal insulin by 20–30% and monitor glucose frequently

    Reduced caloric intake during bowel prep necessitates a modest basal insulin reduction and frequent glucose monitoring to prevent hypoglycemia.

  4. Which glucose level threshold is generally used to define clinically significant hypoglycemia requiring intervention according to ADA standards?

    Answer: < 54 mg/dL (3.0 mmol/L)

    ADA Level 2 hypoglycemia is defined as glucose < 54 mg/dL and requires immediate treatment regardless of symptoms.

  5. A patient with type 2 diabetes and CKD stage 4 is on metformin. What is the MOST appropriate safety action?

    Answer: Discontinue metformin due to risk of lactic acidosis

    Metformin is contraindicated when eGFR falls below 30 mL/min/1.73 m² (CKD stage 4) due to the risk of lactic acidosis.

  6. Which approach BEST prevents insulin injection site lipohypertrophy?

    Answer: Rotate injection sites systematically and change needles with each injection

    Systematic site rotation and using a fresh needle each time prevents the tissue trauma that leads to lipohypertrophy.

  7. A patient with type 1 diabetes presents with nausea, vomiting, and glucose of 320 mg/dL with ketones in urine. They are on an insulin pump. What is the MOST critical first safety step?

    Answer: Administer a correction dose via injection and change the infusion set immediately

    Pump occlusion is a common cause of DKA in pump users; a subcutaneous injection bypasses the occlusion while set replacement is performed.